3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
2
Neurofibromatoses
2
Neurofibroma, Plexiform
2
Glioma
2
Vascular Malformations
1
Skin Diseases, Vascular
1
Primary Malignant Peripheral Nerve Sheath Tumors
1
Neurofibroma
1
NF1
1
Multiple Myeloma
1
Lymphatic Abnormalities
1
Lymphangioma, Cystic
1
Lymphangioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Glioblastoma
1
Central Nervous System Neoplasms
1
Arteriovenous Malformations
1
Advanced Solid Tumor
1
Interventions
Specimen Handling
12
Magnetic Resonance Spectroscopy
12
Temozolomide
11
Radiotherapy
8
Radiation
5
Surgical Procedures, Operative
3
Biopsy
3
trametinib
2
dabrafenib
2
Spinal Puncture
2
Radiotherapy, Intensity-Modulated
2
Genetic Therapy
2
Craniotomy
2
Bevacizumab
2
vorasidenib
1
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
tocilizumab
1
ribociclib
1
pembrolizumab
1
atezolizumab
1
abexinostat
1
Vorinostat
1
Transurethral Resection of Bladder
1
Standard of Care
1
Restraint, Physical
1
Protons
1
Proton Therapy
1
Practice Guidelines as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
mirdametinib
×
90 days
×
Clear all
No trials found.